{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:09:25Z","timestamp":1792786165738,"version":"4.5.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","funder":[{"name":"National Institutes of Health","award":["R01EY016323"],"award-info":[{"award-number":["R01EY016323"]}]},{"name":"UCSD Vision Research Center Core","award":["P30EY022589"],"award-info":[{"award-number":["P30EY022589"]}]},{"name":"National Institutes of Health","award":["5R01EY033847"],"award-info":[{"award-number":["5R01EY033847"]}]},{"name":"National Institutes of Health","award":["5R01EY033847"],"award-info":[{"award-number":["5R01EY033847"]}]},{"name":"National Institutes of Health","award":["T32EY026590"],"award-info":[{"award-number":["T32EY026590"]}]},{"name":"Research to Prevent Blindness","id":[{"id":"https:\/\/ror.org\/04drjs621","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Jacobs Family Retina Fellowship Fund"},{"name":"National Institutes of Health","award":["OT2OD032644"],"award-info":[{"award-number":["OT2OD032644"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>Long-term use of pentosan polysulfate sodium (PPS) for interstitial cystitis has been associated with a sight-threatening pigmentary maculopathy. This study evaluated fluorescence lifetime imaging ophthalmoscopy in PPS maculopathy patients and correlated findings with fundus autofluorescence and optical coherence tomography.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This prospective study included patients with confirmed PPS maculopathy at the University of California, San Diego. All patients underwent same-day multimodal imaging (fluorescence lifetime imaging ophthalmoscopy, fundus photography, fundus autofluorescence, and optical coherence tomography). Disease severity was graded using updated PPS maculopathy criteria. Fluorescence lifetime imaging ophthalmoscopy data were compared with age-matched, sex-matched, and lens status\u2013matched controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Nineteen eyes from 10 PPS patients (mean age 71.2) and 19 eyes from 11 age-sex matched normal controls (mean age 71.5) were included. Both groups had seven pseudophakic and four phakic (P) patients. Pentosan polysulfate sodium maculopathy patients showed characteristic fundus autofluorescence changes and retinal pigment epithelium hypertrophy. Disease severity did not significantly differ within or between phakic and pseudophakic groups. Mean fluorescence lifetime imaging ophthalmoscopy lifetimes in PPS eyes were significantly longer than in controls (P: 905 ps vs. 500 ps,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.019), pseudophakic: 557 ps versus 371 ps,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.044). Lifetimes also varied significantly with maculopathy severity (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05). In 11 eyes, parafoveal foci with very short lifetimes (273\u2013394 ps) were detected and differed significantly from central values (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.030).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Fluorescence lifetime imaging ophthalmoscopy detected significant differences in fluorescence lifetimes between PPS maculopathy patients and controls. Discrete very short lifetime foci may represent early or distinct disease features. Fluorescence lifetime imaging ophthalmoscopy is a promising noninvasive tool for diagnosing and monitoring PPS maculopathy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/iae.0000000000004883","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T14:00:59Z","timestamp":1778853659000},"page":"1817-1827","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["CHARACTERIZATION OF PENTOSAN POLYSULFATE SODIUM MACULOPATHY WITH FLUORESCENCE LIFETIME IMAGING"],"prefix":"10.1097","volume":"46","author":[{"given":"Ines D.","family":"Nagel","sequence":"first","affiliation":[{"name":"Jacobs Retina Center, University of California San Diego, La Jolla, California;"},{"name":"Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Dysli","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Walker","sequence":"additional","affiliation":[{"name":"Hamilton Glaucoma Center, University of California San Diego, La Jolla, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fritz G. P.","family":"Kalaw","sequence":"additional","affiliation":[{"name":"Jacobs Retina Center, University of California San Diego, La Jolla, California;"},{"name":"Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, California;"},{"name":"Division of Ophthalmology Informatics and Data Science, Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, California; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nehal N.","family":"Mehta","sequence":"additional","affiliation":[{"name":"Jacobs Retina Center, University of California San Diego, La Jolla, California;"},{"name":"Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaden H.","family":"Yassin","sequence":"additional","affiliation":[{"name":"Jacobs Retina Center, University of California San Diego, La Jolla, California;"},{"name":"Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Baxter","sequence":"additional","affiliation":[{"name":"Division of Ophthalmology Informatics and Data Science, Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, California; and"},{"name":"Division of Biomedical Informatics, Department of Medicine, University of California San Diego, La Jolla, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahin","family":"Hallaj","sequence":"additional","affiliation":[{"name":"Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, California;"},{"name":"Hamilton Glaucoma Center, University of California San Diego, La Jolla, California;"},{"name":"Division of Ophthalmology Informatics and Data Science, Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, California; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Zangwill","sequence":"additional","affiliation":[{"name":"Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, California;"},{"name":"Hamilton Glaucoma Center, University of California San Diego, La Jolla, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk-Uwe","family":"Bartsch","sequence":"additional","affiliation":[{"name":"Jacobs Retina Center, University of California San Diego, La Jolla, California;"},{"name":"Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Freeman","sequence":"additional","affiliation":[{"name":"Jacobs Retina Center, University of California San Diego, La Jolla, California;"},{"name":"Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyamanga","family":"Borooah","sequence":"additional","affiliation":[{"name":"Jacobs Retina Center, University of California San Diego, La Jolla, California;"},{"name":"Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260922","doi-asserted-by":"crossref","first-page":"821","DOI":"10.2165\/00003495-200666060-00006","article-title":"Pentosan polysulfate: a review of its use in the relief of bladder pain or discomfort in interstitial cystitis","volume":"66","author":"Anderson","year":"2006","journal-title":"Drugs"},{"key":"R2-20260922","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.ophtha.2018.04.026","article-title":"Pigmentary maculopathy associated with chronic exposure to pentosan polysulfate sodium","volume":"125","author":"Pearce","year":"2018","journal-title":"Ophthalmology"},{"key":"R3-20260922","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1001\/jamaophthalmol.2022.6093","article-title":"Two-year outcomes after variable duration of drug cessation in patients with maculopathy associated with pentosan polysulfate use","volume":"141","author":"Jung","year":"2023","journal-title":"JAMA Ophthalmol"},{"key":"R4-20260922","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/jamaophthalmol.2019.3392","article-title":"Phenotypic spectrum of pentosan polysulfate sodium-associated maculopathy: a multicenter study","volume":"137","author":"Hanif","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"R5-20260922","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1097\/IAE.0000000000003844","article-title":"Refining the retinal phenotype of patients with suspected pentosan polysulfate sodium retinopathy","volume":"43","author":"Kalaw","year":"2023","journal-title":"Retina"},{"key":"R6-20260922","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ajo.2021.02.025","article-title":"Pentosan polysulfate maculopathy: prevalence, spectrum of disease, and choroidal imaging analysis based on prospective screening","volume":"227","author":"Wang","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"R7-20260922","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.survophthal.2021.05.005","article-title":"Pentosan polysulfate maculopathy","volume":"67","author":"Lindeke-Myers","year":"2022","journal-title":"Surv Ophthalmol"},{"key":"R8-20260922","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1097\/IAE.0000000000004197","article-title":"Retinal structural changes after cessation of pentosan polysulfate sodium","volume":"44","author":"Kalaw","year":"2024","journal-title":"Retina"},{"key":"R9-20260922","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41433-020-01287-y","article-title":"Fluorescence lifetime imaging ophthalmoscopy: autofluorescence imaging and beyond","volume":"35","author":"Sauer","year":"2021","journal-title":"Eye (Lond)"},{"key":"R11-20260922","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1117\/1.JBO.23.9.091415","article-title":"Review of clinical approaches in fluorescence lifetime imaging ophthalmoscopy","volume":"23","author":"Sauer","year":"2018","journal-title":"J Biomed Opt"},{"key":"R12-20260922","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.oret.2017.10.008","article-title":"Fluorescence lifetime imaging ophthalmoscopy: a novel way to assess macular telangiectasia type 2","volume":"2","author":"Sauer","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"R13-20260922","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1097\/IAE.0000000000001452","article-title":"Fundus autofluorescence lifetimes and central serous chorioretinopathy","volume":"37","author":"Dysli","year":"2017","journal-title":"Retina"},{"key":"R14-20260922","doi-asserted-by":"crossref","first-page":"4856","DOI":"10.1167\/iovs.17-22184","article-title":"Fluorescence lifetimes of drusen in age-related macular degeneration","volume":"58","author":"Dysli","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R15-20260922","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.1364\/BOE.457946","article-title":"Combining fluorescence lifetime with spectral information in fluorescence lifetime imaging ophthalmoscopy (FLIO)","volume":"13","author":"Hammer","year":"2022","journal-title":"Biomed Opt Express"},{"key":"R16-20260922","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1167\/iovs.62.12.2","article-title":"Progressive dysmorphia of retinal pigment epithelium in age-related macular degeneration investigated by fluorescence lifetime imaging","volume":"62","author":"Hammer","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R17-20260922","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1167\/tvst.9.5.20","article-title":"Fundus autofluorescence lifetimes and spectral features of soft drusen and hyperpigmentation in age-related macular degeneration","volume":"9","author":"Hammer","year":"2020","journal-title":"Transl Vis Sci Technol"},{"key":"R18-20260922","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1167\/iovs.17-23336","article-title":"Fundus autofluorescence lifetime patterns in retinitis pigmentosa","volume":"59","author":"Dysli","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R19-20260922","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1167\/iovs.15-18033","article-title":"Fluorescence lifetime imaging in Stargardt disease: potential marker for disease progression","volume":"57","author":"Dysli","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R20-20260922","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1167\/tvst.9.10.33","article-title":"Fluorescence lifetime imaging Ophthalmoscopy (FLIO) in patients with choroideremia","volume":"9","author":"Vitale","year":"2020","journal-title":"Transl Vis Sci Technol"},{"key":"R21-20260922","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1167\/tvst.10.7.11","article-title":"Comparing fluorescence lifetime imaging ophthalmoscopy in atrophic areas of retinal diseases","volume":"10","author":"Goerdt","year":"2021","journal-title":"Transl Vis Sci Technol"},{"key":"R22-20260922","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.oret.2019.04.025","article-title":"Imaging of hydroxychloroquine toxicity with fluorescence lifetime imaging ophthalmoscopy","volume":"3","author":"Sauer","year":"2019","journal-title":"Ophthalmol Retina"},{"key":"R23-20260922","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jcjo.2019.12.001","article-title":"Pentosan-associated maculopathy: prevalence, screening guidelines, and spectrum of findings based on prospective multimodal analysis","volume":"55","author":"Wang","year":"2020","journal-title":"Can J Ophthalmol"},{"key":"R24-20260922","doi-asserted-by":"crossref","first-page":"e097449","DOI":"10.1136\/bmjopen-2024-097449","article-title":"Cross-sectional design and protocol for artificial intelligence ready and equitable atlas for diabetes insights (AI-READI)","volume":"15","author":"Owsley","year":"2025","journal-title":"BMJ Open"},{"key":"R25-20260922","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1167\/iovs.13-13627","article-title":"Quantitative analysis of fluorescence lifetime measurements of the macula using the fluorescence lifetime imaging ophthalmoscope in healthy subjects","volume":"55","author":"Dysli","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R26-20260922","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ajo.2022.07.015","article-title":"Pentosan polysulfate sodium-associated maculopathy: early detection using OCT angiography and choriocapillaris flow deficit analysis","volume":"244","author":"Fogel Levin","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"R27-20260922","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1167\/tvst.9.8.13","article-title":"Influence of lens fluorescence on fluorescence lifetime imaging ophthalmoscopy (FLIO) fundus imaging and strategies for its compensation","volume":"9","author":"Brauer","year":"2020","journal-title":"Transl Vis Sci Technol"},{"key":"R28-20260922","doi-asserted-by":"crossref","first-page":"e0279158","DOI":"10.1371\/journal.pone.0279158","article-title":"Fluorescence lifetime distribution in phakic and pseudophakic healthy eyes","volume":"18","author":"Dysli","year":"2023","journal-title":"PLoS One"},{"key":"R29-20260922","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.1364\/BOE.462559","article-title":"Suppression of natural lens fluorescence in fundus autofluorescence measurements: review of hardware solutions","volume":"13","author":"Schweitzer","year":"2022","journal-title":"Biomed Opt Express"},{"key":"R30-20260922","doi-asserted-by":"crossref","first-page":"5586","DOI":"10.1364\/BOE.400059","article-title":"Comparison of algorithms to suppress artifacts from the natural lens in fluorescence lifetime imaging ophthalmoscopy (FLIO)","volume":"11","author":"Schweitzer","year":"2020","journal-title":"Biomed Opt Express"},{"key":"R31-20260922","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000503567","article-title":"Fluorescence lifetime patterns of retinal pigment epithelium atrophy in patients with Stargardt disease and age-related macular degeneration","volume":"243","author":"Solberg","year":"2020","journal-title":"Ophthalmologica"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/IAE.0000000000004883","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:00:39Z","timestamp":1790096439000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/IAE.0000000000004883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004883","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"value":"0275-004X","type":"print"},{"value":"1539-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]}}}